Gemma Biotherapeutics
- Biotech or pharma, therapeutic R&D
GEMMABio is a Philadelphia-based biotech company founded in 2024 by gene therapy pioneer Dr. James M. Wilson. It focuses on developing and expanding access to affordable gene therapies for rare diseases. GEMMABio raised $34 million in seed funding and signed a $100 million partnership with Brazil’s Fiocruz to deliver gene therapies through Brazil’s public health system. It operates alongside Franklin Biolabs, a contract research organization also founded by Dr. Wilson.
Address
PhiladelphiaPennsylvania
United States
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}